Innovating Works

FUNDACION PRIVADA INSTITUTO DE SALUD GLO...

A stranger
Showing 1 to 20 of 152 results
ACROBAT Newborns: Appraising the Critical Role of prognostic Biomarkers in the Assessment and Triage of sick African n... The main concern of clinicians when addressing sick patients is to promptly identify -i.e., not miss- those at higher risk of severe disease...
2024-10-28 - 2029-12-31 | financed
PULSE-ART: Promoting Understanding and Lifelong learning Successful Education through the ARTs and culture PULSE-ART will produce compelling evidence illustrating the positive impact of arts in education for the enhancement of cultural expression...
2024-10-02 - 2027-10-31 | financed
INCLUDE: Fostering INCLUsive biomeDicine gEps in research and higher education institutions The BioMedical Research and Innovation (R&I) sector is characterised by specific challenges, emphasising the need for intersectional gender...
2024-09-26 - 2026-12-31 | financed
VIDA: VHIO International postDoctoral programme for translAtional research FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA participó en un HORIZON EUROPE HORIZON-MSCA-2023-COFUND-01 The proposed VHIO International postDoctoral programme for translAtional research (VIDA) aims at enabling outstanding junior scientists of a...
2024-09-12 - 2029-12-31 | financed
SUPPORT: Supporting the next generation of African experts on preventing mortality among children living with... The SUPPORT project aims to strengthen health research systems in sub-Saharan African (SSA) countries affected by poverty-related pediatric...
2024-06-11 - 2028-11-30 | financed
c2c: cycling to care Integrating Emotional Well being for Pro environmental Behavior Change "In an era marked by the ""global boiling"" phenomenon, there's an intensifying emotional toll from concurrent crises, manifesting in height...
2024-05-31 - 2027-08-31 | financed
EBO-PEP: The EBO-PEP project : EBOla Zaïre Post-Exposure Prophylaxis, preparedness and efficacy evaluation du... FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA participó en un HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2023-01 Ebola Virus Disease (EVD) outbreaks represent significant threats to public health and require effective countermeasures to minimize transmi...
2024-05-24 - 2027-05-31 | financed
TB-QUEST: Questioning the Epidemiology of Subclinical Tuberculosis FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA processed a HORIZON EUROPE ERC-2023-STG Tuberculosis (TB) remains a major cause of morbidity and mortality around the world. The majority of TB control policies rely on the binary...
2024-04-18 - 2029-04-30 | financed
MalDiProT: Malaria diagnosis and prognosis with an electrokinetic-driven aptamer-based lateral flow assay. FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA processed a HORIZON EUROPE HORIZON-MSCA-2023-PF-01 Malaria remains a public health concern, with 247 million cases and 619,000 deaths reported globally in 2021. Despite the increasing prevent...
2024-04-17 - 2026-09-30 | financed
STOOL4TB: Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with H... FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA processed a HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2023-01 The COVID-19 pandemic had a devastating impact on tuberculosis (TB) control. In 2020, the number of people newly diagnosed with TB decreased...
2024-04-13 - 2025-12-31 | financed
NitRecerCat2425: NitRecerCat The Catalan European Researchers Night FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA participó en un HORIZON EUROPE HORIZON-MSCA-2023-CITIZENS-01 "The Catalan European Researchers’ Night project consists in a two years proposal for 2024 and 2025. The overall proposal is centred on two...
2024-04-02 - 2026-06-30 | financed
REGENERATE: REstorative GENder-specific ExpeRiences in urbAn naTural Environments FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA processed a HORIZON EUROPE HORIZON-MSCA-2023-PF-01 REGENERATE explores gender differences in how urban natural environments (UNE, comprising parks, seaside, and other green and blue spaces in...
2024-03-21 - 2027-02-09 | financed
The META Trial: PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA A RANDOMISED PLACEBO CONTROLLED DOUB... FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA processed a HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2023-01 Diabetes is a common co-morbidity among people living with HIV. Since Oct 2021, we have been conducting a phase III randomised placebo-contr...
2024-03-05 - 2026-12-31 | financed
PROTECT: PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT) FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA processed a HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2023-01 Two vaccines designed for pregnant women, to protect their unborn infant, are entering late phase development and will prevent infections fr...
2024-02-27 - 2027-02-28 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.